treatment of visual hallucinations in schizophrenia by acetylcholinesterase inhibitors: a case report.
Authors
abstract
schizophrenia and various neurological disorders have some signs and symptoms. visual hallucinations are one of such disorders. the related studies in some diseases for example parkinson disease and lewy body dementia indicate that acetylcholine (ach) plays a significant role in neuropsychiatric manifestation and its association with visual hallucination; therefore, visual hallucinations occur due to the depletion of ach. drug therapies such as cholinesterase inhibitors (cheis) for increasing ach level may be beneficial in treating visual hallucination. achei's have been used in the treatment of visual hallucinations in dementia and parkinson's disease. we thought that a similar ach depletion may cause visual hallucinations in patients with schizophrenia and may provide a target for drug treatment. we had a patient with schizophrenia whose psychotic symptoms responded to the treatment plan, but her visual hallucination did not. however, the patient's visual hallucination successfully responded to rivastigmine (achei).this case illustrates the use of an achei in the treatment of refractory visual hallucinations in a patient with schizophrenia.
similar resources
Treatment of Visual Hallucinations in Schizophrenia by Acetylcholinesterase Inhibitors: a case report
Schizophrenia and various neurological disorders have some signs and symptoms. Visual hallucinations are one of such disorders. The related studies in some diseases for example Parkinson Disease and Lewy Body Dementia indicate that Acetylcholine (Ach) plays a significant role in neuropsychiatric manifestation and its association with visual hallucination; therefore, visual hallucinations occur ...
full textAcetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report
BACKGROUND Visual hallucinations are commonly seen in various neurological and psychiatric disorders including schizophrenia. Current models of visual processing and studies in diseases including Parkinsons Disease and Lewy Body Dementia propose that Acetylcholine (Ach) plays a pivotal role in our ability to accurately interpret visual stimuli. Depletion of Ach is thought to be associated with ...
full textAcetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: A review of the literature
BACKGROUND Visual hallucinations occur in various neurological diseases, but are most prominent in Lewy body dementia, Parkinson's disease and schizophrenia. The lifetime prevalence of visual hallucinations in patients with schizophrenia is much more common than conventionally thought and ranges from 24% to 72%. Cortical acetylcholine (ACh) depletion has been associated with visual hallucinatio...
full textA Case Report on Somatoform Disorder: Colorful Visual Hallucinations
Objectives: To report a case of somatoform disorder (not otherwise specified-NOS). Methods: The patient was an eight-year-old boy who complained of anxiety and seeing visual hallucinations of colorful shapes. He was administered ant migraine and antiepileptic drugs. However, no changes were observed. Psychotherapy was started, as well as fluoxetine (20 mg per day). Initial assessments includ...
full textCase report of visual hallucinations in anxiety
Hallucinations rarely occur in individuals with anxiety disorders. This case report describes a 36-year-old male with Social Phobia and Agoraphobia with Panic Attacks who had prominent visual hallucinations that were both distressing and incapacitating. Treatment with sertraline 200 mg/d, clonazepam 1 mg/d, and propranolol 20 mg/day for one month completely resolved both his anxiety and the hal...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of psychiatryجلد ۶، شماره ۴، صفحات ۱۶۱-۱۶۳
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023